MAGNESIUM OXIDE- magnesium oxide tablet 
Marlex Pharmaceuticals Inc

----------

Magnesium Oxide

MAGNESIUM OXIDE 400MG- magnesium oxide 400mg tablet

MarlexPharmaceuticals, Inc.

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Magnesium Oxide Tablets

ACTIVE INGREDIENT (In each tablet)

Magnesium Oxide 400mg (241.3mg elemental magnesium)

Purpose

Antacid

USES

WARNINGS

Ask a doctor if you have

kidney disease

Ask a doctor or pharmacist before use if you are

taking a prescription drug. Antacids may interact with certain prescription drugs.

Do not take

more than 2 tablets in a 24 hour period or use the maximum dosage of this product for more than two weeks, except under the advise and supervision of a physician

If pregnant or breast-feeding,

ask a health professional before use.

Keep out of reach ofchildren.

DIRECTIONS

Antacid Directions:

Magnesium Supplement Directions:

OTHER INFORMATION

INACTIVE INGREDIENTS

colloidal silicon dioxide, croscarmellose sodium, microcrystalline cellulose, stearic acid

Manufactured for/ Distributed by:
Marlex Pharmaceuticals, Inc.
New Castle, DE 19720

Rev. 11/23 AA

PRINCIPAL DISPLAY PANEL

NDC 10135-0786-62
Magnesium Oxide
400 mg
120 TABLETS

786-62

MAGNESIUM OXIDE 
magnesium oxide tablet
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:10135-786
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
MAGNESIUM OXIDE (UNII: 3A3U0GI71G) (MAGNESIUM CATION - UNII:T6V3LHY838) MAGNESIUM CATION400 mg
Inactive Ingredients
Ingredient NameStrength
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
STEARIC ACID (UNII: 4ELV7Z65AP)  
Product Characteristics
ColorwhiteScoreno score
ShapeROUNDSize11mm
FlavorImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:10135-786-62120 in 1 BOTTLE; Type 0: Not a Combination Product11/01/2023
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM00111/01/2023
Labeler - Marlex Pharmaceuticals Inc (782540215)

Revised: 11/2023
Document Id: 0bb32ca5-c694-4f7a-e063-6294a90aa45b
Set id: 0bb322a5-fb92-14de-e063-6294a90a4c1b
Version: 1
Effective Time: 20231101
 
Marlex Pharmaceuticals Inc